236 related articles for article (PubMed ID: 31534141)
1. Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis.
Kumari R; Deshmukh RS; Das S
Nat Commun; 2019 Sep; 10(1):4255. PubMed ID: 31534141
[TBL] [Abstract][Full Text] [Related]
2. Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation.
Zheng W; Tasselli L; Li TM; Chua KF
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573442
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Role of ATP-Citrate Lyase in the Immune System.
Dominguez M; Brüne B; Namgaladze D
Front Immunol; 2021; 12():632526. PubMed ID: 33679780
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ACLY Leads to Suppression of Osteoclast Differentiation and Function Via Regulation of Histone Acetylation.
Guo Q; Kang H; Wang J; Dong Y; Peng R; Zhao H; Wu W; Guan H; Li F
J Bone Miner Res; 2021 Oct; 36(10):2065-2080. PubMed ID: 34155695
[TBL] [Abstract][Full Text] [Related]
5. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
[TBL] [Abstract][Full Text] [Related]
6. ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch.
Zhao S; Torres A; Henry RA; Trefely S; Wallace M; Lee JV; Carrer A; Sengupta A; Campbell SL; Kuo YM; Frey AJ; Meurs N; Viola JM; Blair IA; Weljie AM; Metallo CM; Snyder NW; Andrews AJ; Wellen KE
Cell Rep; 2016 Oct; 17(4):1037-1052. PubMed ID: 27760311
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination.
Sivanand S; Rhoades S; Jiang Q; Lee JV; Benci J; Zhang J; Yuan S; Viney I; Zhao S; Carrer A; Bennett MJ; Minn AJ; Weljie AM; Greenberg RA; Wellen KE
Mol Cell; 2017 Jul; 67(2):252-265.e6. PubMed ID: 28689661
[TBL] [Abstract][Full Text] [Related]
8. ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition.
Guo W; Ma J; Yang Y; Guo S; Zhang W; Zhao T; Yi X; Wang H; Wang S; Liu Y; Dai W; Chen X; Shi Q; Wang G; Gao T; Li C
Clin Cancer Res; 2020 Jun; 26(11):2725-2739. PubMed ID: 32034077
[TBL] [Abstract][Full Text] [Related]
9. Impact of ATP-citrate lyase catalytic activity and serine 455 phosphorylation on histone acetylation and inflammatory responses in human monocytic THP-1 cells.
Dominguez M; Truemper V; Mota AC; Brüne B; Namgaladze D
Front Immunol; 2022; 13():906127. PubMed ID: 36439127
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis.
Carrer A; Trefely S; Zhao S; Campbell SL; Norgard RJ; Schultz KC; Sidoli S; Parris JLD; Affronti HC; Sivanand S; Egolf S; Sela Y; Trizzino M; Gardini A; Garcia BA; Snyder NW; Stanger BZ; Wellen KE
Cancer Discov; 2019 Mar; 9(3):416-435. PubMed ID: 30626590
[TBL] [Abstract][Full Text] [Related]
11. Polarization of Human Macrophages by Interleukin-4 Does Not Require ATP-Citrate Lyase.
Namgaladze D; Zukunft S; Schnütgen F; Kurrle N; Fleming I; Fuhrmann D; Brüne B
Front Immunol; 2018; 9():2858. PubMed ID: 30568658
[TBL] [Abstract][Full Text] [Related]
12. Polyamine regulating protein antizyme binds to ATP citrate lyase to accelerate acetyl-CoA production in cancer cells.
Tajima A; Murai N; Murakami Y; Iwamoto T; Migita T; Matsufuji S
Biochem Biophys Res Commun; 2016 Mar; 471(4):646-51. PubMed ID: 26915799
[TBL] [Abstract][Full Text] [Related]
13. FABP7 Regulates Acetyl-CoA Metabolism Through the Interaction with ACLY in the Nucleus of Astrocytes.
Kagawa Y; Umaru BA; Shima H; Ito R; Zama R; Islam A; Kanno SI; Yasui A; Sato S; Jozaki K; Shil SK; Miyazaki H; Kobayashi S; Yamamoto Y; Kogo H; Shimamoto-Mitsuyama C; Sugawara A; Sugino N; Kanamori M; Tominaga T; Yoshikawa T; Fukunaga K; Igarashi K; Owada Y
Mol Neurobiol; 2020 Dec; 57(12):4891-4910. PubMed ID: 32812201
[TBL] [Abstract][Full Text] [Related]
14. miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.
Xin M; Qiao Z; Li J; Liu J; Song S; Zhao X; Miao P; Tang T; Wang L; Liu W; Yang X; Dai K; Huang G
Oncotarget; 2016 Jul; 7(28):44252-44265. PubMed ID: 27317765
[TBL] [Abstract][Full Text] [Related]
15. mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis.
Martinez Calejman C; Trefely S; Entwisle SW; Luciano A; Jung SM; Hsiao W; Torres A; Hung CM; Li H; Snyder NW; Villén J; Wellen KE; Guertin DA
Nat Commun; 2020 Jan; 11(1):575. PubMed ID: 31996678
[TBL] [Abstract][Full Text] [Related]
16. ATP-citrate lyase deficiency in the mouse.
Beigneux AP; Kosinski C; Gavino B; Horton JD; Skarnes WC; Young SG
J Biol Chem; 2004 Mar; 279(10):9557-64. PubMed ID: 14662765
[TBL] [Abstract][Full Text] [Related]
17. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth.
Lin R; Tao R; Gao X; Li T; Zhou X; Guan KL; Xiong Y; Lei QY
Mol Cell; 2013 Aug; 51(4):506-518. PubMed ID: 23932781
[TBL] [Abstract][Full Text] [Related]
18. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment.
Khwairakpam AD; Shyamananda MS; Sailo BL; Rathnakaram SR; Padmavathi G; Kotoky J; Kunnumakkara AB
Curr Drug Targets; 2015; 16(2):156-63. PubMed ID: 25537655
[TBL] [Abstract][Full Text] [Related]
19. BCAT2 promotes melanoma progression by activating lipogenesis via the epigenetic regulation of FASN and ACLY expressions.
Tian Y; Ma J; Wang H; Yi X; Wang H; Zhang H; Guo S; Yang Y; Zhang B; Du J; Shi Q; Gao T; Guo W; Li C
Cell Mol Life Sci; 2023 Oct; 80(11):315. PubMed ID: 37801083
[TBL] [Abstract][Full Text] [Related]
20. Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation.
Dufort FJ; Gumina MR; Ta NL; Tao Y; Heyse SA; Scott DA; Richardson AD; Seyfried TN; Chiles TC
J Biol Chem; 2014 Mar; 289(10):7011-7024. PubMed ID: 24469453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
